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Abstract Fibroblasts from the progeroid Nijmegen
breakage syndrome that express a truncated version of
the nibrin protein (NBNp70) undergo premature senes-
cence and have an enlarged morphology with high
levels of senescence-associated b-galactosidase,
although they do not have F-actin stress fibres. Growth
of these fibroblasts in the continuous presence of p38
inhibitors resulted in a large increase in replicative
capacity and changed the cellular morphology so that
the cells resembled young normal fibroblasts. A
similar effect was seen using an inhibitor of the p38
downstream effector kinase MK2. These data suggest
that NBNp70 expressing cells undergo a degree of
stress-induced replicative senescence via p38/MK2
activation, potentially due to increased telomere
dysfunction, that may play a role in the progeroid
features seen in this syndrome.
Keywords Cellular morphology  Human ageing 
MAPKAPK2  p38 MAP kinase inhibitors  Progeroid
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Introduction
Nijmegen Breakage Syndrome (NBS) is an autosomal
recessive disorder characterised by microcephaly,
growth retardation, and immunodeficiency accompa-
nied by recurrent infection and lymphoma (Ochs et al.
1997). NBS has been described as a progeroid (rapid
ageing) syndrome (Hofer et al. 2005). NBS individuals
display progeroid-like features, such as sparse and
grey hair, cafe´-au-lait spots and distinctive ‘bird-like’
facies, characterised by a receding forehead, a prom-
inent mid-face with a long nose, and a receding
mandible, all of which become more pronounced with
age (Seemanova et al. 1985). Human ageing has been
linked to the build up of senescent cells during life
since they display deleterious biochemical features
resulting from the expression of degradative enzymes
and inflammatory cytokines, and may contribute to
age-related degenerations in division-competent tis-
sues as a result of reduced proliferative capacity in
organs where cell division is central to normal
function or repair (Kipling et al. 2004; Burton 2009).
Primary lymphocytes and fibroblasts recently explant-
ed from NBS individuals typically show slow growth
and undergo premature replicative senescence that, if
recapitulated in vivo, may underlie some of the
progeroid features seen in NBS (Ranganathan et al.
2001; Cabuy et al. 2005).
Progeroid syndromes (PSs) are widely used as
models for human ageing because, in those aspects
where premature ageing occurs, the process and
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pathology are similar to that seen in normally aged
individuals (Davis et al. 2009; Hofer et al. 2005). The
best-studied PSs are Werner Syndrome (WS), Ataxia
Telangiectasia (AT) and Hutchinson Gilford Progeria
(HGPS), which carry causal mutations in the WRN
RecQ helicase, ataxia telangiectasia checkpoint kinase
ATM, and lamin A/C respectively (Hofer et al. 2005).
Fibroblasts from these individuals show accelerated
ageing in vitro, with WS and AT fibroblasts having a
very abbreviated replicative capacity and HGPS
fibroblasts showing high levels of apoptosis (Tollefs-
bol and Cohen 1984; Tchirkov and Lansdorp 2003;
Bridger and Kill 2004). Based upon such studies it has
been postulated that premature cellular senescence
may underlie many of the ageing features seen in PSs
(Faragher et al. 2009). However, recent data has shown
that premature cellular senescence only occurs in a
subset of PSs that includes WS, AT, HGPS, and ATR-
SS (a version of Seckel Syndrome that has mutations in
the AT and Rad3-related checkpoint kinase ATR)
(Tivey et al. 2013a, 2013b; Davis et al. 2013b).
Cellular senescence in many human cell types
results from the inability of DNA replication to
maintain the telomeres at the ends of chromosomes
resulting in telomere erosion during cell division.
Eventually, the telomeres shorten to the extent that cell
division is halted and the cells enter replicative
senescence (Allsopp et al. 1992). Nibrin (NBN), the
protein affected in NBS, has been suggested to play a
role in telomere length maintenance (Ranganathan
et al. 2001; Verdun and Karlseder 2006). However,
although newly-isolated NBS fibroblasts have rela-
tively short telomeres when compared to newly-
isolated normal fibroblasts, there does not appear to
be a significantly increased rate of telomere erosion
per se, with the replicative capacities of NBS cells
being inversely proportional to the telomere length at
explant (Tauchi et al. 2002; Hou et al. 2012). This does
not exclude a telomere defect in NBS cells, however,
and there is evidence that the numbers of telomere
fusions are elevated (Zhang et al. 2005; Cabuy et al.
2005). In addition, ectopic cellular expression of an
NBN mutant protein that cannot be activated by ATM
results in telomere truncations and fusions (Bai and
Murnane 2003), as does RNAi knockdown of NBN
(Zhang et al. 2005). These data suggest that the
replicative cellular defect may be due to an increased
incidence of telomere fusions, although the mecha-
nism is not well understood (Ranganathan et al. 2001).
Like with NBS, there appears to be no increased rate
of telomere erosion in WS or ATR-SS fibroblasts (Baird
et al. 2004; McNees et al. 2010), suggesting their
premature senescence is independent of telomere ero-
sion. However, both WS and ATR-SS fibroblasts show
telomere instability (Ariyoshi et al. 2007; Crabbe et al.
2004; Pirzio et al. 2008; Casper et al. 2004, 2002), which
may explain the observed increased frequency of telo-
mere-derived sister chromatin exchanges (T-SCEs) seen
in these syndromes (McNees et al. 2010; Hagelstrom
et al. 2010). The premature senescence seen in WS and
ATR-SS fibroblasts appears due, at least in part, to the
activation of the stress-associated p38 MAPK resulting in
what has been termed SIPS (stress-induced premature
senescence) (Toussaint et al. 2002a). p38 inhibition is
able to extend the replicative capacity of WS and ATR-
SS fibroblasts considerably (Davis et al. 2005; Tivey et al.
2013b). Because telomere instability is known to activate
p38 (Iwasa et al. 2003), these data suggest that some of
the premature senescence phenotype may be due to SIPS
resulting from increased telomere instability.
As NBS has progeroid features, accelerated fibro-
blast senescence, and telomere fusions, and NBN is
involved in many of the same DNA damage response
pathways as both WRN and ATR (Pichierri and
Franchitto 2004; Shiotani et al. 2013), we hypothe-
sised that premature senescence in NBS cells might
result from activation of p38 signalling and SIPS. To
address this we used a range of inhibitors of the p38-
signalling pathway, together with molecular profiling,
to test whether the accelerated senescence seen in NBS
fibroblasts requires the p38-signalling pathway.
Materials and methods
The primary dermal fibroblasts used in this work were
derived from biopsies of human tissue and obtained
from the Coriell Cell Repository (Camden, NJ, USA).
GM07166 is from a 20 year old female homozygous
for a deletion of 5 nucleotides in exon 6 of the NBS1
gene resulting in a frameshift, and premature termi-
nation at codon 218. Immunoblot confirms the absence
of wild-type NBN protein in this strain and the
presence of low levels of a C-terminal peptide termed
NBNp70 (Yanagihara et al. 2011); these are referred to
as NBSp70 cells throughout this manuscript. The
normal dermal fibroblast strains (NDFs) have been
described previously (Tivey et al. 2013a).
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All cells were grown in Dulbecco’s modified Eagle
medium (DMEM: Gibco Invitrogen, Paisley, UK)
supplemented with 10 % foetal calf serum (Source
BioScience UK Limited, Nottingham), 2 mM L-glu-
tamine (Invitrogen Life Technologies Ltd., Paisley,
UK), 10,000 U/ml penicillin and 10 mg/ml strepto-
mycin (Sigma, Poole, UK) in an atmosphere of 21 %
O2 and 5 % CO2, and passaged every 4–5 days as
described previously (Davis et al. 2003). Cultures
were not allowed to become confluent at any time in
order to maintain maximal growth rates. Population
doublings (PDs) were calculated according to the
formula: PDs = log(Nt/No)/log2, where Nt is number
of cells counted and No is number of cells seeded.
For experiments using kinase inhibitors the medium
was supplemented with 2.5 lM SB203580 (Tocris
Chemical Co. Bristol, UK), 2.5 lM BIRB 796 (Bagley
et al. 2006), 0.5 lM VX-745 (Bagley et al. 2007) or
5 lM MK2.III [Merck, UK (Anderson et al. 2007)]
dissolved in DMSO, with the medium changed daily. For
controls, an equivalent volume of DMSO was added to
the medium.
To activate the p38-signalling pathway using
anisomycin, immortalised normal AG16409 cells
(NDFtert) were plated onto 100 mm dishes in DMEM
and cultured for 2 days at 37 C, after which the cells
were treated with 30 lM anisomycin (Sigma, Poole,
UK) for 45 min (Davis et al. 2013a).
All other materials and methods used in this article
including immunoblotting, antibodies, senescence-
associated b-galactosidase assay (SAb-gal), and
FITC-phalloidin immunofluorescence have been
described previously (Davis et al. 2013b).
Results
NBSp70 fibroblasts undergo premature cellular
senescence
Primary NBSp70 fibroblasts were grown to senescence
in DMEM either with no supplementation, or in
medium that had been supplemented with various p38
or MK2 inhibitors (illustrated in Fig. 1a, b). Control
NBSp70 fibroblasts had a replicative capacity of
19.6 ± 3.0 PDs (Table 1) that was statistically differ-
ent (p \ 0.036) from the mean replicative capacity of
eight NDF strains of 38.8 ± 10.5 PDs (Table S1). The
NBSp70 replicative capacity was less than that of all
the normal fibroblasts strains used.
Inhibition of p38 rescues the premature senescence
phenotype of NBSp70 cells
Treatment with SB203580 at 2.5 lM increased the
NBSp70 replicative capacity to 36.5 ± 3.0 PDs, a
Fig. 1 Growth characteristics of NBS cells. a example growth
curves in PDs versus days for primary NBSp70 cells supple-
mented with 0.1 % (v/v) DMSO (open circle), 2.5 lM
SB203580 (fill circle), 2.5 lM BIRB 796 (open square) or
0.5 lM VX-745 (fill square). b example growth curves in PDs
versus days for primary NBSp70 cells supplemented with 0.1 %
(v/v) DMSO (open circle) or 5.0 lM MK2.III (fill circle): note
that the NBSp70 cells had already achieved 5.6 PDs prior to
starting the growth experiment. c comparison of the mean
replicative capacity for control NBSp70 cells and NBSp70 cells
treated with SB203580 or MK2.III (Student’s t-test)
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highly statistically significant increase compared to
untreated cells (Table 1; Fig. 1c). The resulting
NBSp70 replicative capacity was now within the range
of the SB203580-treated NDFs of 46.6 ± 12.1 PDs
(p [ 0.21) (Table S1); indeed it was greater than two
of the previously used normal strains. Additionally the
percentage lifespan increase achieved using
SB203580 on NBSp70 cells of approximately 90 %
was considerably greater than previously seen with
NDFs of approximately 30 % (Tivey et al. 2013a).
Significantly increased replicative capacities were
also seen when NBSp70 cells were treated with the
p38 inhibitors BIRB 796 (at 2.5 lM) and VX-745 (at
0.5 lM) (Table 1), which again brought the NBSp70
replicative capacity to within the range seen for
inhibitor-treated NDFs (Table S2). The p38 inhibitors
also resulted in an increased growth rate for the
NBSp70 cells. Finally, treatment of NBSp70 cells with
the MK2 inhibitor MK2.III (Anderson et al. 2007)
significantly increased the replicative capacity to
33.8 ± 0.8 PDs (Table 1), an increase in experimental
lifespan of 101 % (taking into account that the NBSp70
cells were at 5.6 PDs when MK2 inhibition began;
Fig. 1b) which was much greater than has been seen
using this inhibitor on NDFs (Davis et al. 2013a).
Additionally, MK2 inhibition resulted in a more rapid
growth rate in the NBSp70 cells (Fig. 1b).
NBSp70 fibroblasts do not show elevated levels
of F-actin stress fibres
In addition to a reduced replicative capacity, fibro-
blasts isolated from WS and ATR-SS individuals had
an enlarged morphology with extensive F-actin stress
fibres that resembled senescent cells (Davis et al.
2005; Tivey et al. 2013b). Stress fibres result from
activation of p38 via its downstream target MK2 that
phosphorylates the actin binding protein HSP27 (Shi
et al. 2003). Many low PD NBSp70 cells had an
enlarged morphology with an aged and granular
appearance that resembled senescent cells when
compared to low PD AG16409 NDFs, and had an
SAb-gal staining index of 37.6 %. However, in
contrast to WS cells the NBSp70 cells did not have
F-actin stress fibres (Fig. 2, top panels). Following
SB203580 treatment NBSp70 cells were reduced in
size, had an SAb-gal index of 3 % (Fig. 2, middle
panels), and now resembled control AG16409 NDFs
(Fig. 2, bottom panels). Similar results were seen with
BIRB 796, VX-745 and MK2.III (not shown).
Levels of p38 pathway activation are similar
in NBSp70 and normal cells
Fibroblasts from both WS and ATR-SS individuals
show high levels of activated p38 and phosphorylated
HSP27 that correlate with their reduced replicative
capacity and extensive stress fibres (Davis et al. 2005;
Tivey et al. 2013b). Thus, protein extracts were
prepared from low PD primary NBSp70 cells and
immunoblotted with antibodies specific to the phos-
phorylated forms of p38 and HSP27 to assess activa-
tion of the p38 signalling pathway. Phosphorylated
(activated) p38 was not detected in either NBSp70 cells
or in the NDF strain AG16409 (Fig. 3a). Similarly,
although some detectable phosphorylated HSP27 (a
p38 downstream target) was found in NBSp70 cells,
this was at levels similar to that seen in NDFs. The
level of phosphorylated HSP27 was reduced with
SB203580 treatment in both NBSp70 cells and NDFs.
The low levels of phosphorylated HSP27 correlate
with the lack of F-actin stress fibres seen in NBSp70
cells. Likewise no activated MK2 was seen in NBSp70
cells or NDFs, as assessed by the lack of a band shift
(see control lane in Fig. 3b) when using an MK2
antibody that recognises both active and inactive
MK2.
Discussion
Normal human fibroblasts have a limited division
potential and undergo telomere-driven replicative
Table 1 Lifespan of NBSp70 fibroblasts
Condition PDs achieveda Probabilityb
Control 19.6 ± 3.0 (n = 3) na
VX-745 30.1 (n = 1) p \ 0.005c
SB203580 36.5 ± 3.0 (n = 3) p \ 0.002d
BIRB 796 41.7 (n = 1) p \ 0.0001c
MK2.III 33.8 ± 0.8 (n = 2) p \ 0.0082d
a Mean ± SD (sample number) except when a single sample
has been analyzed
b Probability that the lifespan is same as for untreated cells
c z-test
d Student’s t-test
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senescence (Herbig et al. 2004; Allsopp and Harley
1995). At senescence the fibroblasts have an enlarged
granular appearance with extensive arrays of F-actin
stress fibres (Davis et al. 2005). Short telomeres
activate the tumour suppressor p53 that then up-
regulates p21WAF1 resulting in cell cycle arrest. In
addition to activation of p53, short telomeres activate
the stress kinase p38 that can also induce cell cycle
arrest (Iwasa et al. 2003). Activation of p38 results in
the production of F-actin stress fibres via MK2 and
HSP27 phosphorylation (Shi et al. 2003). Thus the
features seen in seen in replicatively senescent cells
result from activation of two distinct molecular
pathways (Iwasa et al. 2003). In addition to telo-
mere-induced replicative senescence, fibroblasts can
undergo a stress-induced cell cycle arrest as a result of
activation of p38 leading to what is termed stress-
induced premature senescence or SIPS (Toussaint
et al. 2002b). SIPS can occur through both exogenous
stress such as high oxygen levels, or endogenous stress
as a result of difficulties during DNA replication or
repair (Toussaint et al. 2002b). These two processes of
telomere-dependent senescence and SIPS synergise to
determine the replicative capacity of human fibro-
blasts (Tivey et al. 2013a).
Fibroblasts derived from various progeroid syn-
dromes have been shown to have a reduced replicative
capacity compared to normal cells; such syndromes
include WS, ATR-SS, AT and HGPS (Davis and
Kipling 2009; Tivey et al. 2013a; Davis et al. 2005;
Tivey et al. 2013b). This reduced replicative potential
has been suggested as contributing to the accelerated
ageing seen in these syndromes (Kipling et al. 2004).
In some cases the reduced replicative capacity is due
to increased telomere dysfunction (AT), and in others
due to problems with DNA replication causing
replication stress that lead to high activation of p38
and a high degree of SIPS (ATR-SS and WS).
NBS is considered a progeroid syndrome and
NBSp70 cells have a much-reduced replicative capac-
ity compared to NDFs. Continuous treatment of
NBSp70 fibroblasts with several p38 inhibitors resulted
in large significant increases in replicative capacity to
within the range seen in inhibitor treated NDFs. The
increases seen for NBSp70 cells were also significantly
greater than the increases seen for inhibitor treated
NDFs. The inhibitors SB203580 and BIRB 796 are
more effective at extending replicative capacity than
VX-745 that is probably due to their greater ability to
inhibit p38 continuously throughout the long-term
Fig. 2 Cellular
morphology, SAb-gal
staining and phalloidin-
FITC staining: BF
brightfield; bar = 100 lm.
The panel for GM07166
SB203580 SAb-gal is a
composite of four separate
views due to the low cell
density; however, the scale
is the same as for the other
panels
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growth of the cells, as has been seen previously using
ATR-SS cells (Tivey et al. 2013b). However, although
NBSp70 fibroblasts have an enlarged morphology, high
SAb-gal staining levels and resemble aged cells to
some degree, all features that are corrected with p38/
MK2 inhibition, they do not have F-actin stress fibres
and there is no obvious activation of p38 or MK2. As
the p38 inhibitors are of different chemotypes and
have different modes of action and potencies (Bagley
et al. 2010), and the effects of p38 inhibitors in NBSp70
cells are matched by an MK2 inhibitor that is a known
downstream effector of p38 (Kyriakis and Avruch
2001), it seems unlikely that these results are due to a
target other than the p38-signalling pathway. These
data suggest that the premature senescence seen in
NBSp70 primary dermal fibroblasts is due (at least in
part) to p38 activation primarily through activation of
the kinase MK2. However, further work using siRNA
technology to target MK2 should be done to corrob-
orate these results when suitable cell material becomes
available; siRNA to target p38 cannot be done for
long-term growth experiments as p38 knockdown
results in cell lethality (our unpublished data).
Given the effect of p38 inhibition on NBSp70 cells,
why is no expression of activated p38 seen in these
cells? A similar situation is seen in NDFs and in
fibroblasts from several other PSs, where p38 inhibi-
tion similarly extends cellular replicative capacity
despite activated p38 not being detectable by immu-
noblot (Tivey et al. 2013a; Davis and Kipling 2009). It
may be that p38 is activated in a transient, cell cycle
dependent, fashion; and indeed a functional role has
been suggested for p38 in regulating the G2/M
transition in the absence of stress, with p38 activation
only being transiently detected at the G2/M transition
(Cha et al. 2007). Another example come from the use
of nucleoside analogs to slow the rate of DNA
replication in U2OS cells (Kopper et al. 2013). Such
treatment leads to a growth arrest that can be prevented
by MK2 inhibition using MK2.III, yet no MK2
activation was seen by immunoblot; is has been
speculated that a low level of MK2 activation occurs
that is confined to the cell nucleus in the nucleoside
treated cells (Kopper et al. 2013). Whatever their
mechanism of action, both serve to illustrate that p38 or
MK2 can be activated sufficiently to have an effect
upon the cell cycle and cellular replicative capacity,
but not sufficiently to make this activation readily
detectable by immunoblot, and thus by extrapolation
potentially not sufficiently to affect cellular morphol-
ogy by triggering the expression of F-actin stress fibres.
Therefore it is possible that the defect in NBSp70 cells
activates p38/MK2 at a specific time in the cell cycle at
a level that is not detectable using immunoblot, but that
is sufficient to cause a significant level of cell cycle
arrest and the observed reduced replicative capacity.
The effect of p38 inhibition on replicative capacity
in NBSp70 cells is similar to that seen in ATR-SS cells,
but smaller than seen in WS cells. Most of the increase
in replicative capacity in NBSp70 cells resulted from
MK2 inhibition, whereas MK2 inhibition only
resulted in a moderate increase in replicative capacity
in WS cells when compared to p38 inhibition, and
MK2 inhibition had little effect in NDFs (Davis et al.
2013a). In addition, MK2 inhibition increased the
Fig. 3 Analysis of stress kinases in NBSp70 cells and NDFs.
a lysates were prepared from cells grown in DMEM ? 0.1 %
(v/v) DMSO d or 2.5 lM SB203580 (SB). Proteins are p38
(arrow indicates p38 band), phospho-p38 (pp38), HSP27 and
phospho-HSP27 (pHSP27). NDFtert ? An are telomerase
immortalised NDFs treated with 30 lM anisomycin for
45 min to activate p38. b lysates were prepared as for (a).
Protein is MK2, arrow indicates phosphorylated MK2 (acti-
vated) in the control lane. NBSp70tert are telomerase immorta-
lised NBSp70 cells used as a control
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growth rates of NBSp70 cells, but had little effect in
either WS cells or NDFs. Finally, both ATR-SS and
WS cells show extensive F-actin stress fibres and p38
activation that are not seen in NBSp70 cells (Tivey
et al. 2013a; Davis et al. 2005; Tivey et al. 2013b).
Thus, the NBSp70 cell phenotypes and their responses
to kinase inhibition appear to be intermediate between
that of WS and ATR-SS cells, and NDFs (summarised
in Table S3).
In WS or ATR-SS cells the lack (or low levels)
of WRNp and ATR results in a high level of
replication stress (Ammazzalorso et al. 2010;
McNees et al. 2010; Ozeri-Galai et al. 2008; Pirzio
et al. 2008) due to a high degree of stalling at DNA
replication forks (Rodriguez-Lopez et al. 2002;
Koundrioukoff et al. 2013), particularly at hard-to-
replicate sequences such as common fragile sites
(CFS), and these sites are expressed in both WS and
ATR-SS cells (Casper et al. 2004; Pirzio et al.
2008). In contrast, replication fork stalling and CFS
expression have not been reported for NBSp70
expressing cells. In addition, both WS and ATR-
SS syndrome cells have an increased level of
telomere dysfunction (Ariyoshi et al. 2007; Crabbe
et al. 2004; Pirzio et al. 2008; Casper et al. 2004,
2002; McNees et al. 2010), and an increase in
telomere fusions is seen in NBSp70 cells that is also
indicative of telomere dysfunction (Zhang et al.
2005; Cabuy et al. 2005). As both telomere
dysfunction and replication stress can activate p38
(Iwasa et al. 2003; Llopis et al. 2012), the data
suggest that the differences in the fibroblast behav-
iour from the three syndromes may simply relate to
the nature of the stress occurring. It is possible that
p38 is activated to a greater extent in WS and ATR-
SS than is seen in NBS as two p38-activating
processes are occurring, replication stress and telo-
mere dysfunction. In NBS cells the only p38-
acitvating process appears to be telomere dysfunc-
tion. Thus, the defect seen in NBSp70 cells results in
a lower level of stress than defects seen in WS or
ATR-SS, and subsequently a lower level of p38
activation.
The data in this paper also suggest that telomere
dysfunction may signal through MK2 since its inhibi-
tion is almost as effective at extending replicative
capacity in NBSp70 cells as p38 inhibition, which is a
suggestion that appears to be novel to this work. Further
support for this idea comes from the use of telomerase
(tert) immortalised NBSp70 cells. Ectopic expression of
tert in these cells does not result in telomere elongation
(unlike in tert-immortalised NDFs) but merely main-
tains short telomere lengths, and the telomere fusions
seen in primary NBSp70 cells are still prevalent,
suggesting that NBNp70 has a dominant negative effect
on aspects of telomere maintenance (Ranganathan et al.
2001; Siwicki et al. 2003). Tert-immortalised NBSp70
fibroblasts have a very slow growth rate compared to
tert-immortalised NDFs (0.16 ± 0.005 PDs/day com-
pared to 0.49 ± 0.02 PDs/day), and MK2 inhibition has
a significant positive effect on this growth rate
(0.23 ± 0.01 PDs/day; p \ 0.0006), although it does
not approach that of NDFs. In contrast, MK2 inhibition
has no effect on the growth rate of tert-immortalised
NDFs that have little (or no) telomere dysfunction
(0.47 ± 0.02 PDs/day; p [ 0.25). Overall, the data
presented in this paper suggest that NBSp70 fibroblasts
undergo a form of premature senescence, possibly as a
result of difficulties in the replication of telomeres, and
this is transduced via the p38/MK2-signalling pathway.
Further work on the possible link between telomere
dysfunction and MK2 activity is clearly warranted in
other systems.
The differential activation of p38 in fibroblasts
from the different PSs may correlate with, or indeed
influence, the in vivo progeroid phenotypes seen, as
the progeroid features are less pronounced in NBS
compared to either WS or ATR-SS. In addition, a
feature of both WS and ATR-SS is the presence of
inflammatory conditions such as type II diabetes
(Rauch 2011; Martin et al. 1999), which is in
contrast to NBS where inflammatory conditions are
not found (Hofer et al. 2005); activated p38 is
strongly associated with inflammatory conditions
(Kumar et al. 2003). It is also possible, if activation
of p38/MK2 and premature cellular senescence do
play a role in the aged features of these syndromes,
that p38 and/or MK2 inhibitors may be a therapeutic
possibility (Davis and Kipling 2006).
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